Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Bambusa Therapeutics Appoints Jonathan I. Lieber as Chief Financial Officer
PRIVATEOct 07, 2026
Position
Chief Financial Officer
Company
Bambusa Therapeutics
Jonathan I. Lieber
BostonBiotechnologyHealth CareTherapeutics
Description
Bambusa Therapeutics announces the appointment of Jonathan I. Lieber as Chief Financial Officer. With over 30 years of experience in the biotechnology sector, Jon will contribute to Bambusa's growth and strategic direction.
Company Information
Company
Bambusa Therapeutics
Location
Boston, Massachusetts, United States
About
Bambusa Therapeutics Inc. is a biotechnology company focused on developing bispecific antibodies for the treatment of immunological and inflammatory disorders. Founded by a team of industry experts and scientific innovators, the company aims to transform the treatment landscape for such diseases. Bambusa leverages validated targets to create therapeutics through innovative antibody engineering. Their goal is to achieve best-in-disease profiles for multiple indications.
Fundz sees it the moment Bambusa Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BostonBiotechnologyHealth CareTherapeutics